Citigroup Inc. (C)

NYSE: C · 即時價格 · USD

137.72

-0.42 (-0.30%)

收盤價： Sep 04, 2026, 3:59 PM

137.75

+0.02%

盤後: 7:59 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

-0.30% (1D)

買價	137.63
市值	231B
營收 (ttm)	81.7B
淨利（ttm）	16.5B
	1.10
	9.25
	14.89
	10.69
P/B (ttm)	1.20
P/S (ttm)	2.83
財報日期	Oct 13, 2026

賣價	137.65
成交量	5,703,478
20 日平均成交量	11,566,663
開盤價	137.43
前收盤價	138.14
當日區間	135.40 - 138.10
52 週範圍	93.66 - 147.96
分析師	n/a
目標價	157.5 (14.36%)
股利	$2.68 (1.94%)
除息日	Aug 3, 2026

關於 C

Citigroup Inc., a diversified financial service holding company, provides various financial products and services to consumers, corporations, governments, and institutions. It operates through five segments: Services, Markets, Banking, U.S. Personal Banking, and Wealth. The Services segment includes treasury and trade solutions, which provides cash management, trade, and working capital solutions to multinational corporations, financial instituti...

[閱讀更多]

產業 Banks - Diversified

類股 Financial Services

IPO 日期 Jan 3, 1977

員工 219,000

證券交易所 NYSE

股票代號 C

網站 https://www.citigroup.com

完整的公司簡介

財務表現

Citigroup 在 2025 年的營收為 85.21B，較前一年的 80.67B 增加 5.63%。淨利為 14.31B，較前期增加 12.81%。

財務報表

分析師預測

根據 20 位分析師的評等，C 的平均評等為「null」。12 個月目標價為 157.5，較最新價格有 14.36% 的上漲空間。

股票預測

財報驚奇

Citigroup 已於 Jul 14, 2026 公布季度財報：

營收為 $24.77B 低於預期 $0, 年增 14.33% 成長.
每股盈餘為 3.14 超出預期 0.43, 年增 53.92% 成長.

下次財報發布

Citigroup Inc. 的下次財報預計於 Oct 13, 2026, 開盤前。
分析師預估營收 ... 升級

價格為何變動

新聞動態

33 分鐘前 · Simply Wall St.

Hikma Pharmaceuticals (LSE:HIK) Stock Fair Value Edges Higher After Bullish Analyst Targets

Price targets for Hikma Pharmaceuticals are currently clustered in the £1,870 to £2,100 range, which sits above the latest fair value estimate of £19.70. Analysts linking these higher targets to Hikma...

34 分鐘前 · Simply Wall St.

Hammerson (LSE:HMSO) Stock Gets Fair Value Bump As Analysts Lift Targets

Hammerson sits at the centre of a fresh round of price target moves, with a central Fair Value estimate now at £3.94 compared with £3.78 previously. Recent research has pushed targets into a range of ...

1 小時前 · Simply Wall St.

Citigroup (C) Stock May Be 31% Undervalued After Record Revenue Quarter

Citigroup stock has delivered a very strong 3 year return, yet current valuation checks suggest the shares may still trade at a discount to what some intrinsic value models imply. For investors, the p...

1 小時前 · Barrons.com

A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?

In a consequential week for Novartis, the Swiss drug maker released results for two of three trials that Wall Street has watched for in the second half of the year.

23 小時前 · MT Newswires

Market Chatter: Anthropic May Give Morgan Stanley, Goldman Sachs Key Roles in $2 Trillion IPO

Anthropic could give Morgan Stanley (MS) and Goldman Sachs (GS) key roles in handling its market deb

第 1 頁，共 2 頁